Current population · 2,231
A Randomized Trial of Nafamostat for Covid-19.
Morpeth SC, Venkatesh B, Totterdell JA, McPhee GM, Mahar RK, Jones M, Bandara...
← ExplorerSource ↗Publication identity
Publication IDCPD-1848
Year2023
PMID38320527
DOI10.1056/EVIDoa2300132
JournalNEJM Evid
AuthorsMorpeth SC, Venkatesh B, Totterdell JA, McPhee GM, Mahar RK, Jones M, Bandara...
First authorMorpeth SC
Senior authorTong SYC
Scientific classification
Research themeCOVID-19 / respiratory viruses
Pathogen groupSARS-CoV-2
Technology / methodClinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew O'Sullivan
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/38320527/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →